Literature DB >> 23253611

Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis.

Yang D Teng1, Susanna C Benn, Steven N Kalkanis, Jeremy M Shefner, Renna C Onario, Bin Cheng, Mahesh B Lachyankar, Michael Marconi, Jianxue Li, Dou Yu, Inbo Han, Nicholas J Maragakis, Jeronia Lládo, Kadir Erkmen, D Eugene Redmond, Richard L Sidman, Serge Przedborski, Jeffrey D Rothstein, Robert H Brown, Evan Y Snyder.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a lethal disease characterized by the unremitting degeneration of motor neurons. Multiple processes involving motor neurons and other cell types have been implicated in its pathogenesis. Neural stem cells (NSCs) perform multiple actions within the nervous system to fulfill their functions of organogenesis and homeostasis. We test the hypothesis that transplanted, undifferentiated multipotent migratory NSCs may help to ameliorate an array of pathological mechanisms in the SOD1(G93A) transgenic mouse model of ALS. On the basis of a meta-analysis of 11 independent studies performed by a consortium of ALS investigators, we propose that transplanted NSCs (both mouse and human) can slow both the onset and the progression of clinical signs and prolong survival in ALS mice, particularly if regions sustaining vital functions such as respiration are rendered chimeric. The beneficial effects of transplanted NSCs seem to be mediated by a number of actions including their ability to produce trophic factors, preserve neuromuscular function, and reduce astrogliosis and inflammation. We conclude that the widespread, pleiotropic, modulatory actions exerted by transplanted NSCs may represent an accessible therapeutic application of stem cells for treating ALS and other untreatable degenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23253611     DOI: 10.1126/scitranslmed.3004579

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  36 in total

1.  Neural stem cells as a therapeutic approach for amyotrophic lateral sclerosis.

Authors:  Laura Ferraiuolo; Ashley Frakes; Brian K Kaspar
Journal:  Mol Ther       Date:  2013-03       Impact factor: 11.454

Review 2.  Cell replacement therapies: is it time to reprogram?

Authors:  Harald M Mikkers; Christian Freund; Christine L Mummery; Rob C Hoeben
Journal:  Hum Gene Ther       Date:  2014-09-17       Impact factor: 5.695

3.  Defining recovery neurobiology of injured spinal cord by synthetic matrix-assisted hMSC implantation.

Authors:  Alexander E Ropper; Devang K Thakor; InBo Han; Dou Yu; Xiang Zeng; Jamie E Anderson; Zaid Aljuboori; Soo-Woo Kim; Hongjun Wang; Richard L Sidman; Ross D Zafonte; Yang D Teng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 4.  The state of the art in stem cell biology and regenerative medicine: the end of the beginning.

Authors:  Evan Y Snyder
Journal:  Pediatr Res       Date:  2017-12-13       Impact factor: 3.756

5.  Polymeric Nanovehicle Regulated Spatiotemporal Real-Time Imaging of the Differentiation Dynamics of Transplanted Neural Stem Cells after Traumatic Brain Injury.

Authors:  Zhe Wang; Yu Wang; Zhiyong Wang; Jun Zhao; J Silvio Gutkind; Avinash Srivatsan; Guofeng Zhang; Hsien-Shun Liao; Xiao Fu; Albert Jin; Xiao Tong; Gang Niu; Xiaoyuan Chen
Journal:  ACS Nano       Date:  2015-06-02       Impact factor: 15.881

6.  Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.

Authors:  Amit K Srivastava; Sarah K Gross; Akshata A Almad; Camille A Bulte; Nicholas J Maragakis; Jeff W M Bulte
Journal:  Exp Neurol       Date:  2016-12-28       Impact factor: 5.330

Review 7.  Hippocampal injury-induced cognitive and mood dysfunction, altered neurogenesis, and epilepsy: can early neural stem cell grafting intervention provide protection?

Authors:  Ashok K Shetty
Journal:  Epilepsy Behav       Date:  2014-01-13       Impact factor: 2.937

8.  Chemically induced specification of retinal ganglion cells from human embryonic and induced pluripotent stem cells.

Authors:  Hamidreza Riazifar; Yousheng Jia; Jing Chen; Gary Lynch; Taosheng Huang
Journal:  Stem Cells Transl Med       Date:  2014-02-03       Impact factor: 6.940

9.  Phenotypic characteristics of human bone marrow-derived endothelial progenitor cells in vitro support cell effectiveness for repair of the blood-spinal cord barrier in ALS.

Authors:  Svitlana Garbuzova-Davis; Jared Ehrhart; Hilmi Mustafa; Alexander Llauget; Kayla J Boccio; Paul R Sanberg; Stanley H Appel; Cesario V Borlongan
Journal:  Brain Res       Date:  2019-09-04       Impact factor: 3.252

Review 10.  Stem cell therapies for the treatment of radiation-induced normal tissue side effects.

Authors:  Marc Benderitter; Fabio Caviggioli; Alain Chapel; Robert P Coppes; Chandan Guha; Marco Klinger; Olivier Malard; Fiona Stewart; Radia Tamarat; Peter van Luijk; Charles L Limoli
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.